Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01107522
Title Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tactical Therapeutics, Inc.


Advanced Solid Tumor

high grade glioma


Carboxyamidotriazole Orotate + Temozolomide

Carboxyamidotriazole Orotate

Age Groups: adult
Covered Countries USA

No variant requirements are available.